NDC Package 50242-142-01 Lunsumio

Mosunetuzumab Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-142-01
Package Description:
1 VIAL in 1 CARTON / 30 mL in 1 VIAL
Product Code:
Proprietary Name:
Lunsumio
Non-Proprietary Name:
Mosunetuzumab
Substance Name:
Mosunetuzumab
Usage Information:
None.
11-Digit NDC Billing Format:
50242014201
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2625129 - mosunetuzumab-axgb 1 MG in 1 ML Injection
  • RxCUI: 2625129 - 1 ML mosunetuzumab-axgb 1 MG/ML Injection
  • RxCUI: 2625129 - mosunetuzumab-axgb 1 MG per 1 ML Injection
  • RxCUI: 2625129 - mosunetuzumab-axgb 1 MG/ML per 1 ML Injection
  • RxCUI: 2625135 - Lunsumio 1 MG in 1 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Genentech, Inc.
    Dosage Form:
    Concentrate - A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA761263
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    12-22-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50242-142-01?

    The NDC Packaged Code 50242-142-01 is assigned to a package of 1 vial in 1 carton / 30 ml in 1 vial of Lunsumio, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is concentrate and is administered via intravenous form.

    Is NDC 50242-142 included in the NDC Directory?

    Yes, Lunsumio with product code 50242-142 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on December 22, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50242-142-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 50242-142-01?

    The 11-digit format is 50242014201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250242-142-015-4-250242-0142-01